CIK: 0001420995 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value ($000): $54,341 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BRK/A | BERKSHIRE HATHAWAY INC DEL | 76 | $40,392 | 74.3% | $330761.80 | +63.0% | CL A | 084670108 |
| ABNB | AIRBNB INC | 35,487 | $4,869 | 9.0% | $115.47 | +19.6% | COM CL A | 009066101 |
| IRON | DISC MEDICINE INC | 78,682 | $3,696 | 6.8% | $49.79 | +0.5% | COM | 254604101 |
| — | RAPT THERAPEUTICS INC | 73,383 | $1,220 | 2.2% | $20.30 | — | COM | 75382E109 |
| — | VIGIL NEUROSCIENCE INC | 192,973 | $1,040 | 1.9% | $0.01 | — | COM | 92673K108 |
| TNYA | TENAYA THERAPEUTICS INC | 291,828 | $744 | 1.4% | $21.49 | -80.5% | COM | 87990A106 |
| XLO | XILIO THERAPEUTICS INC | 249,635 | $527 | 1.0% | $2.41 | +10.5% | COM | 98422T100 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 1,100 | $385 | 0.7% | $220.20 | +61.1% | CL B NEW | 084670702 |
| SANA | SANA BIOTECHNOLOGY INC | 98,353 | $381 | 0.7% | $5.37 | 0.0% | COM | 799566104 |
| — | SURROZEN INC | 718,950 | $352 | 0.6% | $7.08 | — | COM | 86889P109 |
| — | ROVER GROUP INC | 43,607 | $273 | 0.5% | $6.26 | — | COM CL A | 77936F103 |
| COUR | COURSERA INC | 14,188 | $265 | 0.5% | $12.94 | +23.2% | COM | 22266M104 |
| — | VOR BIOPHARMA INC | 91,910 | $195 | 0.4% | $43.10 | — | COM | 929033108 |
| SRZNW | SURROZEN INC | 33,333 | $1 | 0.0% | $1.14 | — | *W EXP 08/01/2 | 86889P117 |